ClinicalTrials.Veeva

Menu

Improving Hypertension Medication Adherence for Older Adults

University of Arizona logo

University of Arizona

Status

Active, not recruiting

Conditions

Hypertension
Aging
Medication Adherence

Treatments

Other: Blood Pressure Technology System M
Other: Blood Pressure Technology System E

Study type

Interventional

Funder types

Other

Identifiers

NCT05610059
R01NR018469

Details and patient eligibility

About

This randomized controlled trial will assess the efficacy and scalability of a blood pressure technology system intervention. The investigators will enroll 224 older adults with hypertension to identify those who are nonadherent for one hypertension medication. The participants will be randomized to one of two groups (112 per group) to use the blood pressure system for 6-months. Both groups receive information about high blood pressure and medications. One group will also receive strategies that can be used to take medications and manage blood pressure. Both groups will complete a mid-assessment at 3-months and a post-assessment at 6-months.

Enrollment

200 patients

Sex

All

Ages

65+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • age 65 years or older
  • self-manage at least one hypertension medication
  • able to read and speak English
  • willing to participate in the study for six months
  • currently have and use an Apple iPhone
  • have hypertension medication adherence ≤ 90% in the last 2 weeks of the 4-week baseline monitoring period using an AARDEX MEMS® cap

Exclusion criteria

  • have inadequate visual acuity (worse than 20/50 corrected near vision on Snellen test)
  • experience severe depression (> 11 on Geriatric Depression Scale Short Form, GDS-15)
  • are at risk for cognitive impairment (< 23 on Montreal Cognitive Assessment, MoCA)
  • been instructed by their healthcare provider to withhold their blood pressure medication

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

200 participants in 2 patient groups

Blood Pressure Technology System M
Other group
Description:
These participants will receive information about high blood pressure, medications and strategies that can be used to take medications and manage blood pressure. They will complete a mid-assessment at 3-months and a post-assessment at 6-months.
Treatment:
Other: Blood Pressure Technology System M
Blood Pressure Technology System E
Other group
Description:
These participants receive information about high blood pressure and medications. They will complete a mid-assessment at 3-months and a post-assessment at 6-months.
Treatment:
Other: Blood Pressure Technology System E

Trial contacts and locations

2

Loading...

Central trial contact

Wendy A Rogers, Ph.D.; Jeannie K Lee, PharmD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems